The prevalence of polypharmacy is increasing in older persons, and it is associated with an increased risk of adverse health outcomes such as falls, adverse drug events, and hospitalizations, even after accounting for comorbidities. In this systemic review, investigators aimed to summarize available tools that can assist clinicians in deprescribing potentially inappropriate medications and that specifically consider frailty or limited life expectancy.
Link: J Am Geriatr Soc (3/2019) (available via Medscape (free access with site registration))